SinusCalm NDC 0220-9285

NDC codes

FDA NDC Directory

Product NDC (as listed)0220-9285Labeler and product segments. Claims need a package NDC.

Product NDC at billing width00220-9285Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
0220-9285-04	00220928504	3 BLISTER PACK in 1 CARTON (0220-9285-04) / 20 TABLET in 1 BLISTER PACKMarketed from Feb 15, 2026

How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): SinusCalm
Generic name (nonproprietary): atropa belladonna, sanguinaria canadensis root, spigelia anthelmia whole
Active ingredients: Spigelia anthelmia — 3 [hp_C]/1Atropa belladonna — 3 [hp_C]/1Sanguinaria canadensis root — 3 [hp_C]/1
Dosage form: Tablet
Route: Oral
Labeler: Boiron
Product type: Over-the-counter drug
Marketing category: Unapproved homeopathic
Marketing start: Feb 15, 2026
Listing expires: Dec 31, 2027
Identifiers: Product ID 0220-9285_4ae58d81-3953-b372-e063-6394a90a8499SPL ID 4ae58d81-3953-b372-e063-6394a90a8499SPL set ID 4ae58d81-3952-b372-e063-6394a90a8499UNII WYT05213GE, WQZ3G9PF0H, N9288CD508

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N400220928504 followed by a unit qualifier and the quantity

Package 00220-9285-04. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Feb 15, 2026.

Indications (excerpt from the label)

Uses* temporarily relieves sinus symptoms due to colds or allergies such as: nasal congestion sinus pain headache

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)